The New York Times
Researchers in Israel reported that a third dose of the Pfizer-BioNTech Covid vaccine can enhance protection in adults older than 60 for at least 12 days — a result that is unsurprising, experts said, and does not indicate long-term benefit. nyti.ms/3nGhYtR